In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

and nowhere is this more apparent than in the biopharmaceutical sector. While traditional biotech hubs in the West contend with policy volatility and funding constraints, countries in the Asia ...

Find out how efficient Asia’s healthcare system is with Prof Himanshu Rai at the Indian Institute of Management Indore ...

Asia Pacific is estimated to grow at the fastest rate during ... is anticipated to grow to $300 billion by 2030. Top Factors in Indian Biotechnology Industry Being one of the most lucrative ...

“We welcomed more than 3,000 attendees, including 1,026 investors and 86 media representatives this year in a testament to the resilience and ingenuity of the biotech sector,” said Sara Jane ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles. While many countries have seen a decline in investment in recent years ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...